D2L Pharma Research Solutions, an integrated pharma service provider offers a year-long course in Pharmaceutical Business Intelligence. The course is expected to provide candidates the much-needed expertise to become business analysts.
The company will take only 10 students for the course and these will be four from B Pharm, four from BDS/MBBS and 2 BE (Biotech) graduates.
The training fee for a year is Rs 90,000. They will also get an opportunity to work on projects focused on global pharma markets. After completing the course, the candidate will get absorbed as a Business Analyst into D2L Pharma team.
Read more from Pharmabiz
Monday, December 22, 2008
Sunday, December 21, 2008
Drug Metabolism and Pharmacokinetics (DMPK) Symposium
Drug Metabolism and Pharmacokinetics (DMPK) Symposium
Jointly organized by National Institute of Pharmaceutical Education and Research (NIPER) & Bristol Meyers Squibb
The main goals of the Symposium are to:
1) provide a better understanding of the role that drug metabolism, drug transporters, pharmacokinetics, and pharmacodynamics play in the drug discovery/development process;
2) evaluate new and current techniques and models associated with drug metabolism and drug transporters, as well as development of pharmacokinetic-pharmacodynamic models;
3) gain insights into the issues encountered during the drug discovery process and the interface between discovery and clinical development; and
4) identify processes for reducing the attrition of drug candidates through a better understanding of metabolism and in vitro and in vivo correlations.
Some of the Speakers at this symposium are:
Dr. Michael Sinz, Bristol-Myers Squibb, USA
Dr. Nuggehally Srinivas, Clintec, Bangalore
Dr. Nimish Vachharanjani, Advinus, Banagalore
Dr. Vijay Gombar, Eli Lilly and Co., USA
Dr. Chandra Prakash, Biogen Idec, USA
REGISTRATION FEES
Students : Rs. 2000/-
Faculty / scientists : Rs. 3000/-
Industry personnel : Rs. 10,000/-
IMPORTANT DATES
Receipt of Abstract : 1st Jan 2009
Intimation of acceptance : 15th Jan 2009
Receipt of Reg. Fee : 1st Jan. 2009
Receipt of Acc. Charges : 1st Jan. 2009
Dates of symposium : 13th & 14th Feb. 2009
Click here for more info
REGISTRATION FORM |DOC| |PDF|
Jointly organized by National Institute of Pharmaceutical Education and Research (NIPER) & Bristol Meyers Squibb
The main goals of the Symposium are to:
1) provide a better understanding of the role that drug metabolism, drug transporters, pharmacokinetics, and pharmacodynamics play in the drug discovery/development process;
2) evaluate new and current techniques and models associated with drug metabolism and drug transporters, as well as development of pharmacokinetic-pharmacodynamic models;
3) gain insights into the issues encountered during the drug discovery process and the interface between discovery and clinical development; and
4) identify processes for reducing the attrition of drug candidates through a better understanding of metabolism and in vitro and in vivo correlations.
Some of the Speakers at this symposium are:
Dr. Michael Sinz, Bristol-Myers Squibb, USA
Dr. Nuggehally Srinivas, Clintec, Bangalore
Dr. Nimish Vachharanjani, Advinus, Banagalore
Dr. Vijay Gombar, Eli Lilly and Co., USA
Dr. Chandra Prakash, Biogen Idec, USA
REGISTRATION FEES
Students : Rs. 2000/-
Faculty / scientists : Rs. 3000/-
Industry personnel : Rs. 10,000/-
IMPORTANT DATES
Receipt of Abstract : 1st Jan 2009
Intimation of acceptance : 15th Jan 2009
Receipt of Reg. Fee : 1st Jan. 2009
Receipt of Acc. Charges : 1st Jan. 2009
Dates of symposium : 13th & 14th Feb. 2009
Click here for more info
REGISTRATION FORM |DOC| |PDF|
Symposium on Clinical Research & Training
National Institute of Pharmaceutical Education and Research (NIPER) is organizing a Symposium on Clinical Research & Training on 20th -22nd Feb. 2009
The main goal of the symposium is to provide advancement in knowledge and skills of persons working or intending to work in clinical research. This symposium will be of special use to professionals and students associated with pharmaceutical & biotechnology industry, academic institutions, regulatory agencies, clinical research organizations and healthcare Industry.
Welcomed to this Symposium are:
* CRAs & Study Coordinators working in the field who are looking for additional training.
* Professionals wanting to change career within the industry/academia to clinical research.
* Professionals willing to get in the field of clinical research.
* Recently employed personnel in academia or industry requiring comprehensive training in clinical research.
Dr. N.K.Ganguly, Advisor, MoHFW, GOI, Dr. Arun Bhatt, Clin Invent, Mumbai, Prof. K.K. Talwar, Director, PGIMER, Chandigarh, Dr. C. Dutt, Torrent, Ahmedabad are some of the Proposed speakers at this symposium.
The topics proposed for discussion in the symposium are:
1. Drug development process
2. Good clinical trials
3. Laws/ regulations governing clinical trials
4. Clinical trials scenario in India
5. Clinical registry in India
6. Ethics Committees / IRBs
7. Clinical trials in pediatric populations
8. Adverse events & ADR reporting
9. Statistical concepts in clinical trials
10. Basics of clinical data management
11. Role of investigators in clinical trials
12. Management of a clinical site
13. Management of clinical trials program
Registration Fees:
Industry: Rs. 10,000/- only
Academia: Rs.5,000/= only
Students: Rs.2,500/= only
(B. Pharm. IV yr. only, M. Pharm., MBBS, MD)
Important Dates
Close of registration : 31st Jan. 2009
Intimation of acceptance : 7th Feb. 2009
Dates of Symposium : 20th -22nd Feb. 2009
click here for more info
Registration form: (word) (PDF)
The main goal of the symposium is to provide advancement in knowledge and skills of persons working or intending to work in clinical research. This symposium will be of special use to professionals and students associated with pharmaceutical & biotechnology industry, academic institutions, regulatory agencies, clinical research organizations and healthcare Industry.
Welcomed to this Symposium are:
* CRAs & Study Coordinators working in the field who are looking for additional training.
* Professionals wanting to change career within the industry/academia to clinical research.
* Professionals willing to get in the field of clinical research.
* Recently employed personnel in academia or industry requiring comprehensive training in clinical research.
Dr. N.K.Ganguly, Advisor, MoHFW, GOI, Dr. Arun Bhatt, Clin Invent, Mumbai, Prof. K.K. Talwar, Director, PGIMER, Chandigarh, Dr. C. Dutt, Torrent, Ahmedabad are some of the Proposed speakers at this symposium.
The topics proposed for discussion in the symposium are:
1. Drug development process
2. Good clinical trials
3. Laws/ regulations governing clinical trials
4. Clinical trials scenario in India
5. Clinical registry in India
6. Ethics Committees / IRBs
7. Clinical trials in pediatric populations
8. Adverse events & ADR reporting
9. Statistical concepts in clinical trials
10. Basics of clinical data management
11. Role of investigators in clinical trials
12. Management of a clinical site
13. Management of clinical trials program
Registration Fees:
Industry: Rs. 10,000/- only
Academia: Rs.5,000/= only
Students: Rs.2,500/= only
(B. Pharm. IV yr. only, M. Pharm., MBBS, MD)
Important Dates
Close of registration : 31st Jan. 2009
Intimation of acceptance : 7th Feb. 2009
Dates of Symposium : 20th -22nd Feb. 2009
click here for more info
Registration form: (word) (PDF)
Thursday, December 18, 2008
New Courses at Lotus Clinical Research Academy
Lotus Clinical Research Academy (LCRA) recently announced that it will commence two courses soon.
M.S IN PHARMACEUTICAL CHEMISTRY - KANSAS UNIVERSITY, USA
and
M.PHARM IN CLINICAL RESEARCH - BIRLA INSTITUTE OF TECHNOLOGY, RANCHI
The former being an online Post Graduate programme, taught by renowned professors from Kansas University which is expected to commence in February 2009. A detailed article appeared in the Pharmabiz today, which stated "The two-year course fee is Rs 16 lakh and banks are open to fund such initiatives for students. After being registered to the course, students will be provided a password to download the entire syllabus along with the video versions of lectures creating a typical classroom environment."
M.S IN PHARMACEUTICAL CHEMISTRY - KANSAS UNIVERSITY, USA
and
M.PHARM IN CLINICAL RESEARCH - BIRLA INSTITUTE OF TECHNOLOGY, RANCHI
The former being an online Post Graduate programme, taught by renowned professors from Kansas University which is expected to commence in February 2009. A detailed article appeared in the Pharmabiz today, which stated "The two-year course fee is Rs 16 lakh and banks are open to fund such initiatives for students. After being registered to the course, students will be provided a password to download the entire syllabus along with the video versions of lectures creating a typical classroom environment."
Thursday, September 11, 2008
Indian Pharma industry going through a paradigm shift: Dr Surinder Singh
"As a regulator we are trying to take several measures so that the Indian Pharma Industry realizes its dreams", affirmed Dr Surinder Singh, Drugs Controller General, Government of India at 6th Pharma Summit 2008: "India Pharma Inc. - An Emerging Global Pharma Hub" organized by the Confederation of Indian Industry (CII) in Mumbai.
More info on the priority areas of DCGI office can be found here
More info on the priority areas of DCGI office can be found here
Monday, July 21, 2008
CREMA ties up with William Harvey Research Limited
CREMA (Clinical Research Education and Management Academy) tied up with William Harvey Research Limited (WHRL).
Click here for more info.
Click here for more info.
Thursday, July 10, 2008
PCI to begin approval of institutions for Pharm D course
An article in Pharmabiz stated today that the Pharmacy Council of India (PCI) is planning to disseminate approval for pharmacy colleges to conduct Pharm D course in India.
Here is a small timeline description of the info found in that article.
July 15 - Application form for approval to be published in the PCI website
July 31 - Date before which the institutions have to apply for inspection.
2nd week of August - Initiation of inspection programme by PCI
4th week of August - Analysis of Inspection report
1st week of september - Distribution of Approval certificates
Click here to read the Circular from PCI regarding Pharm D.
Here is a small timeline description of the info found in that article.
July 15 - Application form for approval to be published in the PCI website
July 31 - Date before which the institutions have to apply for inspection.
2nd week of August - Initiation of inspection programme by PCI
4th week of August - Analysis of Inspection report
1st week of september - Distribution of Approval certificates
Click here to read the Circular from PCI regarding Pharm D.
Wednesday, June 25, 2008
Pharm D - Update
Yet another college in the south is in news for staring Pharm D course and this time it's Amrita University in Kerala.
This university is making hectic efforts to launch the Pharm D course in this academic year itself.
Outsmarting other colleges which have already started offering this course, Amrita University is trying to make tie-ups with University at Buffalo, New York and a University in Canada for this course.
The intake for the first batch (which is expected this year) is 25.
Check out the previous blogs on Pharm D
Pharm D all set to begin
Applications invited for admission to Pharm D
This university is making hectic efforts to launch the Pharm D course in this academic year itself.
Outsmarting other colleges which have already started offering this course, Amrita University is trying to make tie-ups with University at Buffalo, New York and a University in Canada for this course.
The intake for the first batch (which is expected this year) is 25.
Check out the previous blogs on Pharm D
Pharm D all set to begin
Applications invited for admission to Pharm D
Tuesday, June 24, 2008
Master of Science in Applied Pharm Analysis/ Applied Pharm Bioinformatics/ Applied Pharm Microbiology
Two Year Full Time Master of Science Programme In Applied Pharm Analysis/ Applied Pharm Bioinformatics/ Applied Pharm Microbiology (Batch 2008- 2010)
School of Pharmacy & Technology Management (SPTM) of SVKM’s NMIMS University has designed a unique MSc programme with specialization in Applied Pharm Analysis/ Applied Pharm Bioinformatics /Applied Pharm Microbiology
Objective
This MSc programme has been prepared taking into consideration the needs of the Pharmaceutical industry with particular reference to skilled manpower in areas like Analytical, Quality Control, Pharm Microbiology and Bioinformatics. Currently the post graduate courses in Science stream face difficulty in placement and employability due to lack of Pharma industry specific skills.
Intake Capacity
20 seats in each specialization for Applied Pharm Analysis/ Applied Pharm Bioinformatics/ Applied Pharm Microbiology
Important dates:
Last date for issue of application form 28th June 2008(Saturday)
Last date for receipt of application forms 30th June 2008 (Monday)
More info about the Programme
School of Pharmacy & Technology Management (SPTM) of SVKM’s NMIMS University has designed a unique MSc programme with specialization in Applied Pharm Analysis/ Applied Pharm Bioinformatics /Applied Pharm Microbiology
Objective
This MSc programme has been prepared taking into consideration the needs of the Pharmaceutical industry with particular reference to skilled manpower in areas like Analytical, Quality Control, Pharm Microbiology and Bioinformatics. Currently the post graduate courses in Science stream face difficulty in placement and employability due to lack of Pharma industry specific skills.
Intake Capacity
20 seats in each specialization for Applied Pharm Analysis/ Applied Pharm Bioinformatics/ Applied Pharm Microbiology
Important dates:
Last date for issue of application form 28th June 2008(Saturday)
Last date for receipt of application forms 30th June 2008 (Monday)
More info about the Programme
Friday, June 20, 2008
APCDA to set up pharmacy college in Hyderabad
The Andhra Pradesh Chemists & Druggists Association (APCDA) is planning to set up a pharmacy college in Hyderabad. The proposed college would be exclusively for the family members of pharmacy traders in the state !
According to the association it had set up Andhra Pradesh Chemists and Druggists Association Trust, in order to carry out the proposed plan and run the day-today activities of the college. The college would be coming up at the existing 1800 sq ft premises of APCDA in Hyderabad. The association stated that it is setting up the college mainly with a view to provide professional education to the family members of chemists and druggists and enable them to support their family business.
"We formed a trust last week to carry out the plan and run the college. The college would come up in our existing premise and in the future if required, we would shift the college into a separate campus in the city" said, Dr Ghisulal Jain, president, Andhra Pradesh Chemists and Druggists Association.
The association is yet to decide on the courses, which upcoming college would be offering. The fund would be raised from the association members and the wholesale dealers. It is also learnt that the association would approach the pharma companies to support their move and each block would be named in after the sponsors.
Dr Jain further added that the college would provide all practical knowledge to the students, including practical knowledge on the preparation of bill and educating the consumers. He stated that most of the colleges are not offering this kind of practical knowledge to the students.
According to the association it had set up Andhra Pradesh Chemists and Druggists Association Trust, in order to carry out the proposed plan and run the day-today activities of the college. The college would be coming up at the existing 1800 sq ft premises of APCDA in Hyderabad. The association stated that it is setting up the college mainly with a view to provide professional education to the family members of chemists and druggists and enable them to support their family business.
"We formed a trust last week to carry out the plan and run the college. The college would come up in our existing premise and in the future if required, we would shift the college into a separate campus in the city" said, Dr Ghisulal Jain, president, Andhra Pradesh Chemists and Druggists Association.
The association is yet to decide on the courses, which upcoming college would be offering. The fund would be raised from the association members and the wholesale dealers. It is also learnt that the association would approach the pharma companies to support their move and each block would be named in after the sponsors.
Dr Jain further added that the college would provide all practical knowledge to the students, including practical knowledge on the preparation of bill and educating the consumers. He stated that most of the colleges are not offering this kind of practical knowledge to the students.
Thursday, June 12, 2008
Ranbaxy & Daiichi - A deal like never before.
A transaction of over 10000 crores and it occupied most part of the business newspapers. Guess its really worth.
Daiichi Sankyo, Japan's third largest pharmaceutical company announced that it will acquire the entire shareholding of the Sellers in Ranbaxy and further seek to acquire the majority of the voting capital of Ranbaxy at a price of Rs 737 per share with the total transaction value expected to be between US $3.4 to US $4.6 billion.
This is the largest transaction involving an Indian pharmaceutical company. Daiichi initiated the bid and this will catapult Daiichi to become the 15th biggest drugmaker in the world from the current 22 and give access to 60 countries from the present 15.
Indian pharma industry has for sure got some good lessons from this acquistition.
Is this something referred to as "a deal like never before" ?!
Daiichi Sankyo, Japan's third largest pharmaceutical company announced that it will acquire the entire shareholding of the Sellers in Ranbaxy and further seek to acquire the majority of the voting capital of Ranbaxy at a price of Rs 737 per share with the total transaction value expected to be between US $3.4 to US $4.6 billion.
This is the largest transaction involving an Indian pharmaceutical company. Daiichi initiated the bid and this will catapult Daiichi to become the 15th biggest drugmaker in the world from the current 22 and give access to 60 countries from the present 15.
Indian pharma industry has for sure got some good lessons from this acquistition.
Is this something referred to as "a deal like never before" ?!
Wednesday, June 11, 2008
Applications invited for admission to Pharm D
As discussed in previous blogs, following the green signal from MOH Annamalai university has invited applications for admission to Six Year Integrated Post Graduate in Pharm. D Degree Programme for the academic year 2008-2009.
Eligibility for admission:
A pass in H. Sc (10+2 level) [Academic stream] with 50% of marks in Mathematics, Physics, Chemistry, Biology (Botany and Zoology) or any other equivalent qualification approved by Annamalai University.
For SC/ST: A pass in the above subjects.
Age limit: Should have completed 17 years as on 31.12.2008
Selection Process:
Selection of candidates to the Pharm. D Programme will be made on the basis of the performance of the candidates in the qualifying examination besides an interview.
Application form and prospectus can be obtained from The Registrar, Annamalai University, Annamalainagar – 608 002 from 09.06.2008 onwards on payment of Rs.500/- in Person or by sending a Demand Draft obtained on or after 09.06.2008 drawn in favour of The Registrar, Annamalai University, Annamalainagar from any Bank, payable at Chennai along with a self-addressed stamped thick kraft envelope of size 30 cm x 24 cm (stamps affixed to the value of Rs.30/-) with the name of the programme. The Name and Address of the Candidate should be clearly indicated on the backside of the Demand Draft also.
Issue of Applications in the University cash counter: Only during working days (Holidays: Public Holidays, All Saturdays and Sundays).
Dates to Remember:
1. Issue of Application forms commences from: 09.06.2008
2. Last Date for issue and receipt of filled in application forms: 30.06.2008
Eligibility for admission:
A pass in H. Sc (10+2 level) [Academic stream] with 50% of marks in Mathematics, Physics, Chemistry, Biology (Botany and Zoology) or any other equivalent qualification approved by Annamalai University.
For SC/ST: A pass in the above subjects.
Age limit: Should have completed 17 years as on 31.12.2008
Selection Process:
Selection of candidates to the Pharm. D Programme will be made on the basis of the performance of the candidates in the qualifying examination besides an interview.
Application form and prospectus can be obtained from The Registrar, Annamalai University, Annamalainagar – 608 002 from 09.06.2008 onwards on payment of Rs.500/- in Person or by sending a Demand Draft obtained on or after 09.06.2008 drawn in favour of The Registrar, Annamalai University, Annamalainagar from any Bank, payable at Chennai along with a self-addressed stamped thick kraft envelope of size 30 cm x 24 cm (stamps affixed to the value of Rs.30/-) with the name of the programme. The Name and Address of the Candidate should be clearly indicated on the backside of the Demand Draft also.
Issue of Applications in the University cash counter: Only during working days (Holidays: Public Holidays, All Saturdays and Sundays).
Dates to Remember:
1. Issue of Application forms commences from: 09.06.2008
2. Last Date for issue and receipt of filled in application forms: 30.06.2008
Clinical Research Professionals - Needs in India
Every day there is a new institute coming up with a Clinical Research Training course. The existing ones expand their operations to other metros.
With three new institutes which I came to know in the last two of days, I wonder if any one get a statistics on the number of institutes offering clinical research courses rather than the statistics on the number of clinical research professionals required by the industry.
I found one such statistics and here it is:
40 - Number of clinical research training institutes in India.
5,000 - Number of trained professionals that these institutes produce annually.
11,000 - Number of trained professionals needed per year currently.
50,000 - Number of trained professionals required by the year 2010.
Will I confuse the readers by leaving the quote from Aaron Levenstein "Statistics are like bikinis. What they reveal is suggestive, but what they conceal is vital."
Well, I may not ;)
With three new institutes which I came to know in the last two of days, I wonder if any one get a statistics on the number of institutes offering clinical research courses rather than the statistics on the number of clinical research professionals required by the industry.
I found one such statistics and here it is:
40 - Number of clinical research training institutes in India.
5,000 - Number of trained professionals that these institutes produce annually.
11,000 - Number of trained professionals needed per year currently.
50,000 - Number of trained professionals required by the year 2010.
Will I confuse the readers by leaving the quote from Aaron Levenstein "Statistics are like bikinis. What they reveal is suggestive, but what they conceal is vital."
Well, I may not ;)
Thursday, May 29, 2008
PharmD course all set to begin
Pharm.D. awareness program was held at Manipal College of Pharmaceutical Sciences on 1st March 2008.
Earlier the PCI has selected 20 pharmacy institutions in India (Manipal College of Pharmaceutical Sciences is one among the 20 colleges in the proposal)and submitted the proposal to the Indian Ministry of Health and Family Welfare for their review and approval.
The Union health ministry has at last given the green signal for the introduction of Pharm.D course. Major prerequisites for starting the Pharm.D course included proper teaching and building infrastructure, tie-up with any 300-bedded hospital or own hospital and prior permission from the Pharmacy Council of India (PCI).
To maintain the quality of program PCI has approved an intake of only 30 students per batch.
The curriculum will include regular Pharmacy subjects as well as sufficient exposure in clinical pharmacy practices (Hospital rounds and partial Clinical training in 4th& 5th year and complete 1 year training in the hospital in last year of the course).
Earlier the PCI has selected 20 pharmacy institutions in India (Manipal College of Pharmaceutical Sciences is one among the 20 colleges in the proposal)and submitted the proposal to the Indian Ministry of Health and Family Welfare for their review and approval.
The Union health ministry has at last given the green signal for the introduction of Pharm.D course. Major prerequisites for starting the Pharm.D course included proper teaching and building infrastructure, tie-up with any 300-bedded hospital or own hospital and prior permission from the Pharmacy Council of India (PCI).
To maintain the quality of program PCI has approved an intake of only 30 students per batch.
The curriculum will include regular Pharmacy subjects as well as sufficient exposure in clinical pharmacy practices (Hospital rounds and partial Clinical training in 4th& 5th year and complete 1 year training in the hospital in last year of the course).
Tuesday, April 29, 2008
Indian Pharmacopoeia 2007
Dr Anbumani Ramadoss, Hon’ble Minister for Health and FW, Government of India released the Indian Pharmacopoeia 2007 on 18th December, 2007 and the prescribed effective date of Indian Pharmacopoeia 2007 was 1st April 2008. Since some of the stakeholders expressed their inability to implement IP 2007 from the effective date, The Indian Pharmacopoeia Commission in consultation with Drug Regulatory and other concerned authorities extended the date of implementation of IP 2007 not later than 1st July 2008.
IP 2007 comes in three volumes. Volume 1 contains the General Notices, Preface, the structure of the IPC, Acknowledgements, Introduction, and the General Chapters. Volume 2 deals with the General Monographs on Drug Substances, Dosage Forms and Pharmaceutical Aids (A to M). Volume 3 contains Monographs on Drug Substances, Dosage Forms and Pharmaceutical Aids (N to Z) followed by Monographs on Vaccines and Immunosera for Human use, Herbs and Herbal products, Blood and blood-related products, Biotechnology products and Veterinary products.
The IP Commission has strictly advised the stakeholders are advised to procure the authenticated copy of the IP 2007.
The IP 2007 can be procured from the office of the Secretary-cum-Scientific Director, IP Commission at CIPL Campus, Raj Nagar, Sector 23, Ghaziabad – 201 002 (UP) through Demand Draft @ Rs. 15000/- (Rupees fifteen thousand only) issued in favour of "Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission" payable at Ghaziabad.
Other Distribution Centres:
M/s Pharma Book Syndicate,
4-3-375, Ansuya Bhawan Opp.Lane to Central Bank,
Bank Street, Hyderabad-500095.
Phone:- 23445666, 23445622, 23445644,
Fax:- 040- 23445611
E-mail : info@ pharmabooksyndicate.com
Educational Book Centre,
133, Gala Complex, Din Dayal Upadhyay Road,
Mulund (W),
Mumbai-400080.
Phone :- + 91-22-2560 3324 Fax:- 91-22- 25685341
E-mail: ebc@vsnl.net
M/s Educational Book Agency (India),
5 D , Kamala Nagar ,
New Delhi.
Phone : 23844216, 41530228
Fax: + 91-11-23842077, Mobile:- 98 11175522
E-Mail : eda@airtelbroadbrand.in
IP 2007 comes in three volumes. Volume 1 contains the General Notices, Preface, the structure of the IPC, Acknowledgements, Introduction, and the General Chapters. Volume 2 deals with the General Monographs on Drug Substances, Dosage Forms and Pharmaceutical Aids (A to M). Volume 3 contains Monographs on Drug Substances, Dosage Forms and Pharmaceutical Aids (N to Z) followed by Monographs on Vaccines and Immunosera for Human use, Herbs and Herbal products, Blood and blood-related products, Biotechnology products and Veterinary products.
The IP Commission has strictly advised the stakeholders are advised to procure the authenticated copy of the IP 2007.
The IP 2007 can be procured from the office of the Secretary-cum-Scientific Director, IP Commission at CIPL Campus, Raj Nagar, Sector 23, Ghaziabad – 201 002 (UP) through Demand Draft @ Rs. 15000/- (Rupees fifteen thousand only) issued in favour of "Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission" payable at Ghaziabad.
Other Distribution Centres:
M/s Pharma Book Syndicate,
4-3-375, Ansuya Bhawan Opp.Lane to Central Bank,
Bank Street, Hyderabad-500095.
Phone:- 23445666, 23445622, 23445644,
Fax:- 040- 23445611
E-mail : info@ pharmabooksyndicate.com
Educational Book Centre,
133, Gala Complex, Din Dayal Upadhyay Road,
Mulund (W),
Mumbai-400080.
Phone :- + 91-22-2560 3324 Fax:- 91-22- 25685341
E-mail: ebc@vsnl.net
M/s Educational Book Agency (India),
5 D , Kamala Nagar ,
New Delhi.
Phone : 23844216, 41530228
Fax: + 91-11-23842077, Mobile:- 98 11175522
E-Mail : eda@airtelbroadbrand.in
Friday, April 25, 2008
QIP 2008 - 2009
Following the issue of application form for admission to M.Pharm in Tamilnadu, application forms for QIP (Quality Improvement Programme)(Masters and Ph.D) is available now.
Click here to download the application form
Last date for receipt of filled in application is 15.05.2008.
Following institutions have QIP Cells and offer admission to M.Pharm. Degree Programme and Ph.D. Programme in various disciplines existing in these institutions
• Delhi Institute of Pharmaceutical Sciences & Research
• University College of Pharmaceutical Sciences, Kakatiya University, Warangal
• J.S. S. College of Pharmacy, Ooty
• Department of Pharmaceutical Technology, Jadavpur University
• K.L.E.’s College of Pharmacy, J.N.M.C. Campus, Belgaum
• Department of Pharmaceutical Sciences, Doctor Harisingh Gour Vishwavidyalaya, Sagar, M.P
• Pharmacy Department, Faculty of Technology & Engineering, The Maharaja Sayajirao University of Baroda
• Department of Pharmacy, Birla Institute of Technology
• Poona College of Pharmacy
• Manipal College of Pharmaceutical Sciences
Click here to download the application form
Last date for receipt of filled in application is 15.05.2008.
Following institutions have QIP Cells and offer admission to M.Pharm. Degree Programme and Ph.D. Programme in various disciplines existing in these institutions
• Delhi Institute of Pharmaceutical Sciences & Research
• University College of Pharmaceutical Sciences, Kakatiya University, Warangal
• J.S. S. College of Pharmacy, Ooty
• Department of Pharmaceutical Technology, Jadavpur University
• K.L.E.’s College of Pharmacy, J.N.M.C. Campus, Belgaum
• Department of Pharmaceutical Sciences, Doctor Harisingh Gour Vishwavidyalaya, Sagar, M.P
• Pharmacy Department, Faculty of Technology & Engineering, The Maharaja Sayajirao University of Baroda
• Department of Pharmacy, Birla Institute of Technology
• Poona College of Pharmacy
• Manipal College of Pharmaceutical Sciences
Wednesday, April 23, 2008
DCGI - FDC issue -Latest update
In a latest move to eradicate the irrational FDCs, the DCGI has seeked
from the industrial associations like OPPI, IPA, IDMA, CIPI, a list of
FDC drugs which the industry would voluntarily remove from the market.
In an initial phase, the drugs common in the list from the industries
and the DCGI's office will be recalled and for the rest of the drugs,
the DCGI will take the assistance from Pharmacoepia commission.
CIPI has already made a list of around 110 drugs (most of them belonging
to the banned, absurd and rejected category) its members are willing to
voluntarily withdraw from the market if the DCGI allows them to
manufacture and market the rest of the contentious 294 FDC drugs.
Although the eradication process moving in a slow pace (for various
reasons) this recent move is certainly promising to kick start the
withdrawl of irrational FDCs.
from the industrial associations like OPPI, IPA, IDMA, CIPI, a list of
FDC drugs which the industry would voluntarily remove from the market.
In an initial phase, the drugs common in the list from the industries
and the DCGI's office will be recalled and for the rest of the drugs,
the DCGI will take the assistance from Pharmacoepia commission.
CIPI has already made a list of around 110 drugs (most of them belonging
to the banned, absurd and rejected category) its members are willing to
voluntarily withdraw from the market if the DCGI allows them to
manufacture and market the rest of the contentious 294 FDC drugs.
Although the eradication process moving in a slow pace (for various
reasons) this recent move is certainly promising to kick start the
withdrawl of irrational FDCs.
Monday, April 21, 2008
TN M. Pharm counselling announced
The application form for admission to M.Pharm (2008-2009) is now being issued.
Click here to download the application
Click here to download the application
Sunday, April 20, 2008
MSc in Pharmacology
All India Institute of Medical Sciences offers MSc in Pharmacology and MSc Drug assay (Pharmacology)
Eligibility:
(a) B.Sc. (Hons.) Human Biology,
(b) B.V.Sc.,
(c) B. Pharmacy or
(d) an equivalent three years B.Sc. (Hons.) degree course.
For more details:
All India Institute of Medical Sciences
Ansari Nagar,
New Delhi 110029
Ph: 011-26588500
Fax 011-26588789
www.aiims.ac.in
Eligibility:
(a) B.Sc. (Hons.) Human Biology,
(b) B.V.Sc.,
(c) B. Pharmacy or
(d) an equivalent three years B.Sc. (Hons.) degree course.
For more details:
All India Institute of Medical Sciences
Ansari Nagar,
New Delhi 110029
Ph: 011-26588500
Fax 011-26588789
www.aiims.ac.in
Wednesday, March 12, 2008
International Conference on Clinical Research
Institute of Clinical Research (India)has organised an International Conference on "Global trends in clinical research India 2008" under the sponsorship of Indian Council of Medical Research.
Venue: Hotel Intercontinental , Mumbai
Date: March 14th- 15th 2008
Who should attend:
* Senior executive level decision makers from Indian and International Pharmaceutical
companies and contract research organizations (CRO)
* Government and public policy officials
* Academia
* Clinical Research Professionals
* Principal investigators
* Post-graduate students entering pharmaceutical/CRO industry
Some of the speakers listed in the conference agenda are:
* Padma Bhushan N.K. Ganguly
Former Director General, Indian Council of Medical Research, New Delhi
* Surinder Singh
Drugs Controller General India, Ministry of Health & Family Welfare, Govt. of India
*K. K. Tripathi
Advisor, Department of Biotechnology, Govt. of India
For more details click here
Venue: Hotel Intercontinental , Mumbai
Date: March 14th- 15th 2008
Who should attend:
* Senior executive level decision makers from Indian and International Pharmaceutical
companies and contract research organizations (CRO)
* Government and public policy officials
* Academia
* Clinical Research Professionals
* Principal investigators
* Post-graduate students entering pharmaceutical/CRO industry
Some of the speakers listed in the conference agenda are:
* Padma Bhushan N.K. Ganguly
Former Director General, Indian Council of Medical Research, New Delhi
* Surinder Singh
Drugs Controller General India, Ministry of Health & Family Welfare, Govt. of India
*K. K. Tripathi
Advisor, Department of Biotechnology, Govt. of India
For more details click here
Tuesday, March 11, 2008
NIPER - Admission Notification for Ph.D Programmes-July, 2008
Applicatons are called for admission to Ph.D programmes at NIPER.
Details of eligibility, qualifications, distribution of seats, admission procedure and other relevant information are available in the Information Brochure and also in the Institute’s website www.niper.gov.in.
28th April 2008 - Last date for issue of Information Brochure in person at NIPER, S.A.S. Nagar
28th April 2008 - Last date for receipt of completed applications at NIPER, S.A.S. Nagar
6th July 2008 - Written test
Details of eligibility, qualifications, distribution of seats, admission procedure and other relevant information are available in the Information Brochure and also in the Institute’s website www.niper.gov.in.
28th April 2008 - Last date for issue of Information Brochure in person at NIPER, S.A.S. Nagar
28th April 2008 - Last date for receipt of completed applications at NIPER, S.A.S. Nagar
6th July 2008 - Written test
NIPER Joint Entrance Examination-2008 (NIPER-JEE 2008)
The National Institute of Pharmaceutical Education and Research (NIPER) has published information regarding its Joint Entrance Examination - JEE 2008
Following is the list of various disciplines offered through the NIPER institutions
NIPER, Ahmedabad: Biotechnology, Natural Products, Pharmaceutics
NIPER, Hajipur: Biotechnology, Pharmacoinformatics, Pharmacy Practice
NIPER, Hyderabad: Medicinal Chemistry, Pharmaceutical Analysis, Pharmacology & Toxicology
NIPER, Kolkata: Medicinal Chemistry, Natural Products, Pharmacoinformatics
NIPER, S.A.S. Nagar: Biotechnology, Medicinal Chemistry, Natural Products, Pharmaceutical Analysis, Pharmaceutical Management, Pharmaceutical Technology (Biotechnology), Pharmaceutical Technology (Bulk Drugs), Pharmaceutical Technology (Formulations), Pharmaceutics, Pharmacoinformatics, Pharmacology & Toxicology, Pharmacy Practice, Regulatory Toxicology, Traditional Medicine
Details of eligibility, qualifications, availability of programmes, admission procedure and other relevant information are available in the Information Brochure and also in the Institute’s website www.niper.gov.in/niperjee2008.html.
Dates to Remember:
28th April 2008 - Last date for issue of Information Brochure in person from the Office of Organizing Chairperson, NIPER-JEE 2008, NIPER, S.A.S. Nagar
28th April 2008 - Last date for receipt of completed applications in the office of Organizing Chairperson, NIPER-JEE 2008, NIPER, S.A.S. Nagar
8th June 2008 - Written test
Following is the list of various disciplines offered through the NIPER institutions
NIPER, Ahmedabad: Biotechnology, Natural Products, Pharmaceutics
NIPER, Hajipur: Biotechnology, Pharmacoinformatics, Pharmacy Practice
NIPER, Hyderabad: Medicinal Chemistry, Pharmaceutical Analysis, Pharmacology & Toxicology
NIPER, Kolkata: Medicinal Chemistry, Natural Products, Pharmacoinformatics
NIPER, S.A.S. Nagar: Biotechnology, Medicinal Chemistry, Natural Products, Pharmaceutical Analysis, Pharmaceutical Management, Pharmaceutical Technology (Biotechnology), Pharmaceutical Technology (Bulk Drugs), Pharmaceutical Technology (Formulations), Pharmaceutics, Pharmacoinformatics, Pharmacology & Toxicology, Pharmacy Practice, Regulatory Toxicology, Traditional Medicine
Details of eligibility, qualifications, availability of programmes, admission procedure and other relevant information are available in the Information Brochure and also in the Institute’s website www.niper.gov.in/niperjee2008.html.
Dates to Remember:
28th April 2008 - Last date for issue of Information Brochure in person from the Office of Organizing Chairperson, NIPER-JEE 2008, NIPER, S.A.S. Nagar
28th April 2008 - Last date for receipt of completed applications in the office of Organizing Chairperson, NIPER-JEE 2008, NIPER, S.A.S. Nagar
8th June 2008 - Written test
Monday, March 10, 2008
ICRI to offer courses in four more cities
Institute of Clinical Research India (ICRI) which already offers
clinical research courses at its campus located at Delhi, Ahmedabad,
Mumbai, Bangalore is now set to offer its courses in four new cities.
New institutes are to be set up at Hyderabad, Calcutta, Chennai and
Chandigarh and these are expected to function from April 2008. There is
already a tough competition among the institutes offering clinical
research courses and it seems that ICRI has a little advantage over the
others by offering M.Sc in clinical research, which no other institute
in India is offering currently.
There is a huge potential for clinical research in India, outsourcing
possibilities are quite high here. Is the scenario same as that which
existed about four years ago?
CT Industry started blooming then and institutes like ICRI seemed to
produce the required CR professionals. But a training institute is not
all that is sufficient to make India meet the standards.
Also there are several institutes coming up in every major metro and the
cost of these courses are coming down gradually, with the rising
competition, will the CT boom face a downfall like the one faced by the
IT industry?
Well.. there is a saying "Early bird get the crumb". And I have heard
another one too "The second mouse gets the cheese"
Which ever the case be, hope one doesn't be a loser.
clinical research courses at its campus located at Delhi, Ahmedabad,
Mumbai, Bangalore is now set to offer its courses in four new cities.
New institutes are to be set up at Hyderabad, Calcutta, Chennai and
Chandigarh and these are expected to function from April 2008. There is
already a tough competition among the institutes offering clinical
research courses and it seems that ICRI has a little advantage over the
others by offering M.Sc in clinical research, which no other institute
in India is offering currently.
There is a huge potential for clinical research in India, outsourcing
possibilities are quite high here. Is the scenario same as that which
existed about four years ago?
CT Industry started blooming then and institutes like ICRI seemed to
produce the required CR professionals. But a training institute is not
all that is sufficient to make India meet the standards.
Also there are several institutes coming up in every major metro and the
cost of these courses are coming down gradually, with the rising
competition, will the CT boom face a downfall like the one faced by the
IT industry?
Well.. there is a saying "Early bird get the crumb". And I have heard
another one too "The second mouse gets the cheese"
Which ever the case be, hope one doesn't be a loser.
Friday, March 7, 2008
ICH-GCP CLINICAL RESEARCH WORKSHOP (15-16 MARCH 2008)
This workshop has been developed to provide overview of clinical research process with a comprehensive review of ICH GCP, USFDA CFR 21, Schedule Y and the elements involved in coordinating a clinical trial.
Who Should Attend?
· Medicine / Life Sciences / Science Graduates & Post Graduates & Students.
· Entry level & Junior CRCs, CRAs and other clinical research professionals with limited experience.
· Anyone interested in the field of clinical research.
Following topics will be covered during the workshop by industry experts :
· Fundamentals of Clinical Research
· Ethical Concerns and Human Subject Protection
· Regulatory Issues
· Subject Recruitment & Retention
· Conduct of Clinical Trials
· Adverse Event Reporting
Course Objectives : Upon completion of the workshop, the attendee should be able to understand the clinical research fundamentals, conduct and management of clinical trials, ethical issues and regulatory issues.
Dates of Workshop : 15-16 March 2008 (Saturday & Sunday) - Timings : 9 a.m. to 5 p.m.
Last Date of Registration : 13th March 2008. Limited seats available.
Registration Fee : Rs.4,500/-
Payment Mode : By Cash or Bank Draft/Cheque favouring `Tenet Health Edutech Pvt. Ltd., payable at New Delhi.
Workshop Venue : Cliniminds, C-55 First Floor, Preet Vihar, Main Vikas Marg, Delhi 110092
Certificates: Certificates of Participation will be issued to all participants.
For Registration & Information Please Contact
Cliniminds
C-55 First Floor, Preet Vihar,
Main Vikas Marg, Delhi 110092
Mobile : 9871072560; 9810068241; 9999851016;
Email : info@cliniminds. com; Website : www.cliniminds. com
Who Should Attend?
· Medicine / Life Sciences / Science Graduates & Post Graduates & Students.
· Entry level & Junior CRCs, CRAs and other clinical research professionals with limited experience.
· Anyone interested in the field of clinical research.
Following topics will be covered during the workshop by industry experts :
· Fundamentals of Clinical Research
· Ethical Concerns and Human Subject Protection
· Regulatory Issues
· Subject Recruitment & Retention
· Conduct of Clinical Trials
· Adverse Event Reporting
Course Objectives : Upon completion of the workshop, the attendee should be able to understand the clinical research fundamentals, conduct and management of clinical trials, ethical issues and regulatory issues.
Dates of Workshop : 15-16 March 2008 (Saturday & Sunday) - Timings : 9 a.m. to 5 p.m.
Last Date of Registration : 13th March 2008. Limited seats available.
Registration Fee : Rs.4,500/-
Payment Mode : By Cash or Bank Draft/Cheque favouring `Tenet Health Edutech Pvt. Ltd., payable at New Delhi.
Workshop Venue : Cliniminds, C-55 First Floor, Preet Vihar, Main Vikas Marg, Delhi 110092
Certificates: Certificates of Participation will be issued to all participants.
For Registration & Information Please Contact
Cliniminds
C-55 First Floor, Preet Vihar,
Main Vikas Marg, Delhi 110092
Mobile : 9871072560; 9810068241; 9999851016;
Email : info@cliniminds. com; Website : www.cliniminds. com
Wednesday, March 5, 2008
State Drug Controllers
Check the following link for the list of Drug Controllers statewise.
http://www.cdsco.nic.in/html/STATE%20DRUGS1.htm
http://www.cdsco.nic.in/html/STATE%20DRUGS1.htm
One Day Seminar on “Generic Drugs: Opportunities, Challenges and Trends”
IDMA is organizing a one day seminar on ‘Generic Drugs: Opportunities, Challenges and Trends’ is to be conducted on April 04, 2008 at Sunville, Banquet Room, Worli, Mumbai.
Eminent speakers will present the following topics at the seminar
• Key note address on : Generic Drugs- Global Market opportunities & Trends
• Barriers in Generic Drugs growth strategies and solutions
• Lifecycle & Portfolio Management of Generic drugs
• Super generics – Value addition to Generics
• Regulatory Issue on Generics
• IP issues in Generic Drugs
• Overview of Biogenerics/Biosimilar or follow-on Protein Drugs
• Promoting Generics at Retail Pharmacy
• Panel Discussion : Generics in India
The Seminar will provide innovative ideas for the Pharmaceutical manufacturers specially the Product Managers, Business Development Managers, SMES, Marketing and Sales Managers.
Registration Fees:-
• Rs. 1500/- for IDMA Members
• Rs. 2000/- for Non IDMA Members
For registration form and more details click here
Eminent speakers will present the following topics at the seminar
• Key note address on : Generic Drugs- Global Market opportunities & Trends
• Barriers in Generic Drugs growth strategies and solutions
• Lifecycle & Portfolio Management of Generic drugs
• Super generics – Value addition to Generics
• Regulatory Issue on Generics
• IP issues in Generic Drugs
• Overview of Biogenerics/Biosimilar or follow-on Protein Drugs
• Promoting Generics at Retail Pharmacy
• Panel Discussion : Generics in India
The Seminar will provide innovative ideas for the Pharmaceutical manufacturers specially the Product Managers, Business Development Managers, SMES, Marketing and Sales Managers.
Registration Fees:-
• Rs. 1500/- for IDMA Members
• Rs. 2000/- for Non IDMA Members
For registration form and more details click here
Wednesday, January 23, 2008
Indian Pharmacopoeia 2007 released in Chennai
After its launch in Delhi last month, the Indian Pharmacopoeia (IP) 2007, having many new features to match with its counterparts in developed countries and encompassing over 1500 monographs, was formally released in Chennai on January 21. The new monographs would be made effective from April 2008.
Dr GN Singh of Indian Pharmacopoeia Commission released the massive document, prepared by the Indian Pharmacopoeia Commission. The release function was attended by Debashish Pandy, joint secretary, union ministry of health, Indian Pharmacopoeia Commission deputy director, south zone Shanti Gunasekharan, state drug controller Anbu Elango, other senior officials and industry representatives.
The new edition comes out in 3 volumes with 300 additional monographs has many new features. Besides, the 175 new monographs of chemicals and dosage forms, it has monographs on vaccines, immunosera, herbs, herbal products, blood and blood-related products, biotechnology and veterinary products.
The fifth edition of the standard-setting document has been prepared in accordance with the principles and designed plan decided by the Scientific Body of the Indian Pharmacopoeia Commission. In addition to the past practices of requesting for comments, the contents of revised appendices and monographs have been publicized on the website of the Indian Pharmacopoeia Commission, for collecting comments widely from various institutions and organizations.
The pharmacopoeia standards included in this publication adhere to the concept of harmonization with those used internationally, also keeping in view technological status for manufactures and analysis of different sectors of the industry, without compromising with the quality of the products.
Cross referencing has been avoided and uniformity of presentation of subject matter was kept. Categories of a drug, dosage & usual available strength of dosage forms have been omitted. Classical chemical tests for identification of an article have been almost eliminated & more specific IR & UV spectrophotometric tests have been introduced.
Use of Chromatographic methods has been greatly extended to cope with the need for more specificity in assays and test for pyrogens were virtually eliminated. The BET (bacterial endotoxin test) are going to be applicable to more items.
Dr GN Singh of Indian Pharmacopoeia Commission released the massive document, prepared by the Indian Pharmacopoeia Commission. The release function was attended by Debashish Pandy, joint secretary, union ministry of health, Indian Pharmacopoeia Commission deputy director, south zone Shanti Gunasekharan, state drug controller Anbu Elango, other senior officials and industry representatives.
The new edition comes out in 3 volumes with 300 additional monographs has many new features. Besides, the 175 new monographs of chemicals and dosage forms, it has monographs on vaccines, immunosera, herbs, herbal products, blood and blood-related products, biotechnology and veterinary products.
The fifth edition of the standard-setting document has been prepared in accordance with the principles and designed plan decided by the Scientific Body of the Indian Pharmacopoeia Commission. In addition to the past practices of requesting for comments, the contents of revised appendices and monographs have been publicized on the website of the Indian Pharmacopoeia Commission, for collecting comments widely from various institutions and organizations.
The pharmacopoeia standards included in this publication adhere to the concept of harmonization with those used internationally, also keeping in view technological status for manufactures and analysis of different sectors of the industry, without compromising with the quality of the products.
Cross referencing has been avoided and uniformity of presentation of subject matter was kept. Categories of a drug, dosage & usual available strength of dosage forms have been omitted. Classical chemical tests for identification of an article have been almost eliminated & more specific IR & UV spectrophotometric tests have been introduced.
Use of Chromatographic methods has been greatly extended to cope with the need for more specificity in assays and test for pyrogens were virtually eliminated. The BET (bacterial endotoxin test) are going to be applicable to more items.
Tuesday, January 22, 2008
IDMA for strengthening CDSO, not in favour of CDA
Indian Drug Manufacturers' Association (IDMA) has suggested to the central government that the centre should strengthen the existing Central Drugs Control Organization (CDSCO) as recommended by Dr Mashelkar Committee and as declared in Pharmaceutical Policy 2002, instead of forming Central Drug Authority (CDA).
In a memorandum submitted recently to the joint director, Rajya Sabha Secretariat, the IDMA suggested that the centre should create strong, well equipped, independent and professionally managed CDSCO and to create separate division under CDSCO as per recommendations of Dr Mashelkar Committee. It has also suggested not to create a Central Drugs Authority by substituting a drugs Technical Advisory Board constituted under Section 5 of the Drugs and Cosmetic Act, 1940 and Ayurveda, Shidha and Unani Drugs Technical Advisory Board constituted under Section 33 C of the Act.
According to the IDMA, both these statutory bodies are broad based and are technical in nature. On the other hand, the proposed CDA will have only five members to be appointed by the central Government. The provision of section 5 of the proposed bill indicates that the central government is not bound to appoint technical experts on the Central Drugs Authority. It also said that the Drugs and Cosmetics Act, 1940 and its implementation is highly technical in nature and requires the advisory bodies comprising technically qualified experts.
It may be noted that the Drugs and Cosmetics (Amendment) Bill 2007 was presented in Rajya Sabha on August 21, 2007 and was later referred to the Parliamentary standing committee to examine and put forth its suggestions. The committee invited suggestions from pharma associations and other stake holders on formation of CDA and these associations and other stake holders sent their suggestions to the committee in writing.
In a memorandum submitted recently to the joint director, Rajya Sabha Secretariat, the IDMA suggested that the centre should create strong, well equipped, independent and professionally managed CDSCO and to create separate division under CDSCO as per recommendations of Dr Mashelkar Committee. It has also suggested not to create a Central Drugs Authority by substituting a drugs Technical Advisory Board constituted under Section 5 of the Drugs and Cosmetic Act, 1940 and Ayurveda, Shidha and Unani Drugs Technical Advisory Board constituted under Section 33 C of the Act.
According to the IDMA, both these statutory bodies are broad based and are technical in nature. On the other hand, the proposed CDA will have only five members to be appointed by the central Government. The provision of section 5 of the proposed bill indicates that the central government is not bound to appoint technical experts on the Central Drugs Authority. It also said that the Drugs and Cosmetics Act, 1940 and its implementation is highly technical in nature and requires the advisory bodies comprising technically qualified experts.
It may be noted that the Drugs and Cosmetics (Amendment) Bill 2007 was presented in Rajya Sabha on August 21, 2007 and was later referred to the Parliamentary standing committee to examine and put forth its suggestions. The committee invited suggestions from pharma associations and other stake holders on formation of CDA and these associations and other stake holders sent their suggestions to the committee in writing.
Monday, January 21, 2008
IPGA to announce date, theme of 60th IPC at Delhi
With the next Indian Pharmaceutical Congress (IPC) scheduled to be held in the national capital under the aegis of Indian Pharmacy Graduates Association (IPGA), the host organization will meet here on January 23, to set the ball rolling for the event by constituting the local organizing committee.
The IPG is planning to hold the 60th IPC in the second week of December 2008, preferably from Friday to Sunday. There was also suggestion for organizing the event in the first week of December. However, the dates for the mega event will soon be fixed in the meeting scheduled this month. Besides the venue, the theme of the conference also will be announced at the scheduled meeting.
It was announced in the last IPC held at Varanasi from December 20-23 that the prestigious pharma event will be held in Delhi under the banner of the IPGA, a member of the Indian Pharmaceutical Congress Association. DCGI Dr M Venketeshwarlu has been named as the president of the IPCA already.
``We are already in the process of finalizing the venues for the event. Hopefully, we will have a clear idea of everything in the first meeting itself. We are expecting 10,000 delegates this year, as all those from the industry and the academic circles are keen to come to Delhi,'' Nasa said.
The IPC at Varanasi, hosted by the Department of Pharmaceuticals of the Banaras Hindu University saw around 5000 delegates. Going by the expected number of delegates, the Delhi event is going to create a record of sorts. Hence, the IPGA is looking for elaborate arrangements to outshine the past events.
Indian Pharmaceutical Congress Association (IPCA) is the apex body representing Indian pharmacists working in various capacities, viz. community pharmacists, hospitals pharmacists, in industry (in production, R&D, quality control, quality assurance and marketing), regulatory officials, academicians and other disciplines and areas of work.
Having over 20,000 pharmacists as its members, it has five constituents - the Indian Pharmaceutical Association, the Indian Pharmacy Graduates Association, the Indian Hospital Pharmacists' Association, the Association of Pharmaceutical Teachers of India and the All India Drugs Control Officer's Confederation. The first IPC was held in Kolkota in 1948. The Varanasi IPC has the theme of `Pharma Vision 2020 - product, patient, practice.'
The IPG is planning to hold the 60th IPC in the second week of December 2008, preferably from Friday to Sunday. There was also suggestion for organizing the event in the first week of December. However, the dates for the mega event will soon be fixed in the meeting scheduled this month. Besides the venue, the theme of the conference also will be announced at the scheduled meeting.
It was announced in the last IPC held at Varanasi from December 20-23 that the prestigious pharma event will be held in Delhi under the banner of the IPGA, a member of the Indian Pharmaceutical Congress Association. DCGI Dr M Venketeshwarlu has been named as the president of the IPCA already.
``We are already in the process of finalizing the venues for the event. Hopefully, we will have a clear idea of everything in the first meeting itself. We are expecting 10,000 delegates this year, as all those from the industry and the academic circles are keen to come to Delhi,'' Nasa said.
The IPC at Varanasi, hosted by the Department of Pharmaceuticals of the Banaras Hindu University saw around 5000 delegates. Going by the expected number of delegates, the Delhi event is going to create a record of sorts. Hence, the IPGA is looking for elaborate arrangements to outshine the past events.
Indian Pharmaceutical Congress Association (IPCA) is the apex body representing Indian pharmacists working in various capacities, viz. community pharmacists, hospitals pharmacists, in industry (in production, R&D, quality control, quality assurance and marketing), regulatory officials, academicians and other disciplines and areas of work.
Having over 20,000 pharmacists as its members, it has five constituents - the Indian Pharmaceutical Association, the Indian Pharmacy Graduates Association, the Indian Hospital Pharmacists' Association, the Association of Pharmaceutical Teachers of India and the All India Drugs Control Officer's Confederation. The first IPC was held in Kolkota in 1948. The Varanasi IPC has the theme of `Pharma Vision 2020 - product, patient, practice.'
Subscribe to:
Posts (Atom)